Florence, Italy

Antonio Guidi

This inventor holds 1 USPTO granted patent. Top assignee: Menarini Ricerche S.p.a.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Guidi. Retrieved from https://idiyas.com/inventor/antonio-guidi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Guidi: Innovator in Pharmaceutical Compounds

Introduction

Antonio Guidi is a notable inventor based in Florence, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Antonio Guidi holds a patent for "Linear basic compounds having NK-2 antagonist activity and formulations thereof." This patent describes compounds of formula (I) that are useful as antagonists of tachykinins, specifically targeting neurokinin A. The pharmaceutical formulations comprising these compounds are designed to offer new treatment options.

Career Highlights

Guidi is associated with Menarini Ricerche S.p.a., a prominent company in the pharmaceutical industry. His work focuses on innovative solutions that address various medical needs, showcasing his commitment to advancing healthcare.

Collaborations

Antonio has collaborated with esteemed colleagues, including Alessandro Sisto and Valerio Caciagli. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Antonio Guidi's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…